Specifically, these approaches used distinct reference genes (PCBP1 for DNA-based detection in colon cancer and RPLP0 for RNA-based detection in rectal cancer), which may affect direct comparability between cohorts. This evidence concerns the gene RPLP0 and colonic neoplasm.